Gilead Sciences, Inc. (GILD) Tops Q3 EPS by 1c, Sales Fall Inline
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $124.44 +0.55%
EPS Growth %: -462.7%
Financial Fact:
Selling, general and administrative: 831M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -462.7%
Financial Fact:
Selling, general and administrative: 831M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Gilead Sciences, Inc. (NASDAQ: GILD) reported Q3 EPS of $1.02, $0.01 better than the analyst estimate of $1.01. Revenue for the quarter came in at $2.12 billion versus the consensus estimate of $2.11 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Reiterated at Overweight by Cantor Fitzgerald: Yeztugo Total TRx Down
- Gilead Sciences (GILD) Reiterated at Overweight by Cantor Fitzgerald post CFO Chat
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
